Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Acquisition

Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Underperformer

871.3500 2.05 (0.24%)

NSE Sep 29, 2025 10:23 AM

Near 52W Low of ₹856.30

Volume: 72,170

Cohance Lifesciences Ltd.

13 Jun 2024

871.35

0.24%

Company Update

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Disclosure under Regulation 30 of the SEBI LODR regarding Acquisition

More from Cohance Lifesciences Ltd.

All Rapid Results

Recommended

Market opens higher, Dixon Tech to buy stake in Q Tech India for Rs 553 crore

Trendlyne Marketwatch | 29 Sep 2025, 10:02AM

The new H1B fee: Who will it hurt the most?

The Baseline | 26 Sep 2025

Five Interesting Stocks Today - September 26, 2025

The Baseline | 26 Sep 2025